75
CONNECT-AV - A prospective , multi-center clinical study of the BD WavelinQ EndoAVF System for the creation of arteriovnous AV Fistula in patients requiring dialysis ( CONNECT-AV ). Principal investigator : Stephen Hohmann , MD .
DELIVER - A prospective , single-arm , multi-center study of the metavention integrated radio frequency denervation system to improve glycemic control in type 2 diabetic subjects . Principal investigator : James Choi , MD .
ENTRUST - A Phase 3 , randomized , double-blind , placebo-controlled study to evaluate the efficacy and safety of Pegozafermin in subjects with severe hypertrigylceridemia ( SHTG ). Principal investigator : Cara East , MD .
FLOW - Study focused on the effect of semaglutide vs placebo in Type 2 diabetics with chronic kidney disease . Principal investigator : Cara East , MD .
GREAT - Global Registry for Endovascular Aortic Treatment . Principal investigator : Dennis Gable , MD .
HORIZON – A randomized double-blind , placebocontrolled , multi-center trial assessing the impact of lipoprotein ( a ) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease : HORIZON outcomes study . Principal investigator : Cara East , MD .
INCEPTION - A randomized , controlled , multicenter , open-label trial comparing a hospital postdischarge care pathway involving aggressive LDL-C management that includes inclisiran with usual care versus usual care alone in patients with a recent acute coronary syndrome ( VICTORION-INCEPTION ). Principal investigator : Cara East , MD .
OCEAN ( a ) - A double-blind , randomized , placebocontrolled , multi-center study assessing the impact of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and elevated lipoprotein ( a ). Principal investigator : Cara East , MD .
PERSPECTIVE - A multi-center , randomized , doubleblind , active-controlled study to evaluate the effects of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction . Principal investigator : Cara East , MD .
PLAQUE - A multi-center , randomized , double-blind , placebo-controlled , parallel-group Phase IIIb study evaluating the effect of inclisirin on atherosclerotic plaque progression assessed by coronary computed tomography angiography ( CCTA ) in participants with a diagnosis of non-obstructive coronary artery disease without previous cardiovascular events . Principal investigator : Cara East , MD .
PREVENT - A randomized double-blind , placebocontrolled , multi-center trial , assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease ( VICTORION-2 PREVENT ). Principal investigator : Cara East , MD .
REDEFINE - Efficacy and safety of cagrilintide s . c . 2.4 mg in combination with semaglutide s . c . 2.4 mg ( CagriSema s . c . 2.4 mg / 2.4 mg ) once-weekly in participants with overweight or obesity . Principal investigator : Priscilla Hollander , MD .
REDEFINE 3 - The cardiovascular safety of cagrilintide 2.4 mg s . c . in combination with semaglutide 2.4 mg s . c . ( CagriSema 2.4 mg s . c .) once weekly in participants with obesity and established cardiovascular disease . Principal investigator : Cara East , MD .
REDEFINE 4 - Efficacy and safety of cagrilinitide 2.4 mg s . c . in combination with semaglutide 2.4 mg s . c . ( CagriSema s . c . 2.4 mg / 2.4 mg ) once weekly compared to tirzepatide 15 mg s . c . once-weekly in participants with obesity . Principal investigator : Priscilla Hollander , MD .
VESALIUS - A double-blind , randomized , placebocontrolled , multi-center study to evaluate the impact of evolocumab on major cardiovascular events in patients at high cardiovascular risk without prior myocardial infarction or stroke - VESALIUS Study . Principal investigator : Cara East , MD .
WAVE - Prospective , randomized , controlled , multi-center study comparing the merit WRAPSODY endovascular stent graft to percutaneous transluminal angioplasty for treatment of venous outflow circuit stenosis or occlusion in hemodialysis patients . Principal investigator : Stephen Hohmann , MD .
Baylor Scott & White Heart and Vascular Hospital | Clinical Trials and Research